Dr. Mark Kane Interview - August 2005
PATH, Seattle

Publications

• Curr Opin Infect Dis. 2002 Oct;15(5):465-9.
  New immunization initiatives and progress toward the global control of hepatitis B
  Kane MA, Brooks A.
• BMJ. 1997 Apr 5;314(7086):1033-6
  Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board
  Van Damme P, Kane M, Meheus A.

Articles on Dr. Kane

• Seattle Post-Intelligencer. Mark Kane's passion is saving lives: Director of Children's Vaccine Program is intense and engaging.

Organizations

• PATH's Children's Vaccine Program
• Rotavirus Vaccine Program
• The Vaccine Fund
• Global Alliance for Vaccines and Immunization (GAVI)
• UNICEF
• Serum Institute of India

Online Content

• Hepatitis B Vaccine Fact Sheet
• WHO Estimates of Vaccine Coverage, by Country

PDFs

• EPI in Ethiopia
• The Global Alliance for Vaccines and Immunization: Is It a New Model for Effective Public-Private Cooperation in International Public Health? AJPH. 2004 Nov;94(11):1922-5 [Stanford] [Public]
• GAVI Fact Sheet: Scaling up immunization to meet the Millennium Development Goals (MDGs), February 2005
• New Technologies and Underused Vaccines, GAVI 2005
• GAVI Alliance Progress and Achievements, 2005
• The GAVI Alliance
• Global Control of Primary Hepatocellular Carcinoma with Hepatitis B Vaccine: The Contributions of Research in Taiwan, Mark Kane 2003 [Stanford] [Public]
• Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial, Lancet 2005; 365: 1139-46 [Stanford] [Public]
• Vaccine trial as “probe” to define the burden of pneumococcal pneumonia disease, Lancet 2005; 365: 1113-14 [Stanford] [Public]
• The Promise of New Rotavirus Vaccines, N Engl J Med 2006 Jan 5; 354(1):75-77 [Stanford] [Public]
• Rotavirus Vaccine Program, PATH Brochure
• Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis, N Engl J Med 2006;354:11-22. [Stanford] [Public]
• Safety and Efficacy of a Pentavalent Human­ Bovine (WC3) Reassortant Rotavirus Vaccine, N Engl J Med 2006;354:23-33. [Stanford] [Public]
• Vaccine Against Diarrhea-Causing Virus Is Approved, The New York Times, February 4, 2006
• Madhavi Y (2005) Vaccine policy in India. PLoS Med 2(5): e127. [Stanford] [Public]
  

PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH's mission is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviors. For more information please visit: http://www.path.org